Insights into the critical roles of the noncanonical IKKs in the pathogenesis of obesity and insulin resistance led to a screen of chemical inhibitors, identifying amlexanox as an inhibitor for both TBK1 and IKKε (37). This evidence concerns the gene IKBKE and obesity due to melanocortin 4 receptor deficiency.